RBOT Relative Valuation
RBOT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RBOT is overvalued; if below, it's undervalued.
Historical Valuation
Vicarious Surgical Inc (RBOT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -6.01. The fair price of Vicarious Surgical Inc (RBOT) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：2.55
Fair
-0.52
PE
1Y
3Y
5Y
-0.55
EV/EBITDA
Vicarious Surgical Inc. (RBOT) has a current EV/EBITDA of -0.55. The 5-year average EV/EBITDA is -3.20. The thresholds are as follows: Strongly Undervalued below -15.36, Undervalued between -15.36 and -9.28, Fairly Valued between 2.89 and -9.28, Overvalued between 2.89 and 8.97, and Strongly Overvalued above 8.97. The current Forward EV/EBITDA of -0.55 falls within the Historic Trend Line -Fairly Valued range.
-0.29
EV/EBIT
Vicarious Surgical Inc. (RBOT) has a current EV/EBIT of -0.29. The 5-year average EV/EBIT is -3.09. The thresholds are as follows: Strongly Undervalued below -15.38, Undervalued between -15.38 and -9.23, Fairly Valued between 3.06 and -9.23, Overvalued between 3.06 and 9.21, and Strongly Overvalued above 9.21. The current Forward EV/EBIT of -0.29 falls within the Historic Trend Line -Fairly Valued range.
0.00
PS
Vicarious Surgical Inc. (RBOT) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Vicarious Surgical Inc. (RBOT) has a current P/OCF of 0.00. The 5-year average P/OCF is -3.59. The thresholds are as follows: Strongly Undervalued below -22.40, Undervalued between -22.40 and -12.99, Fairly Valued between 5.82 and -12.99, Overvalued between 5.82 and 15.22, and Strongly Overvalued above 15.22. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Vicarious Surgical Inc. (RBOT) has a current P/FCF of 0.00. The 5-year average P/FCF is -3.30. The thresholds are as follows: Strongly Undervalued below -18.86, Undervalued between -18.86 and -11.08, Fairly Valued between 4.49 and -11.08, Overvalued between 4.49 and 12.27, and Strongly Overvalued above 12.27. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Vicarious Surgical Inc (RBOT) has a current Price-to-Book (P/B) ratio of 1.07. Compared to its 3-year average P/B ratio of 1.45 , the current P/B ratio is approximately -26.28% higher. Relative to its 5-year average P/B ratio of 3.00, the current P/B ratio is about -64.42% higher. Vicarious Surgical Inc (RBOT) has a Forward Free Cash Flow (FCF) yield of approximately -280.03%. Compared to its 3-year average FCF yield of -98.51%, the current FCF yield is approximately 184.28% lower. Relative to its 5-year average FCF yield of -71.03% , the current FCF yield is about 294.23% lower.
1.07
P/B
Median3y
1.45
Median5y
3.00
-280.03
FCF Yield
Median3y
-98.51
Median5y
-71.03
Competitors Valuation Multiple
The average P/S ratio for RBOT's competitors is 16.21, providing a benchmark for relative valuation. Vicarious Surgical Inc Corp (RBOT) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of RBOT increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of RBOT in the past 1 year is driven by Unknown.
People Also Watch
MLSS
Milestone Scientific Inc
0.288USD
-4.32%
ORMP
Oramed Pharmaceuticals Inc
3.07USD
3.72%
SHIM
Shimmick Corp
3.08USD
-5.23%
CAMP
CAMP4 Therapeutics Corp
5.99USD
0.00%
ASMB
Assembly Biosciences Inc
30.58USD
-5.35%
BKHA
Black Hawk Acquisition Corp
0USD
0.89%
ALXO
ALX Oncology Holdings Inc
1.08USD
-3.57%
VOR
Vor Biopharma Inc
11.67USD
10.30%
Frequently Asked Questions
Is Vicarious Surgical Inc (RBOT) currently overvalued or undervalued?
Vicarious Surgical Inc (RBOT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -6.01. The fair price of Vicarious Surgical Inc (RBOT) is between to according to relative valuation methord.
What is Vicarious Surgical Inc (RBOT) fair value?
RBOT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Vicarious Surgical Inc (RBOT) is between to according to relative valuation methord.
How does RBOT's valuation metrics compare to the industry average?
The average P/S ratio for RBOT's competitors is 16.21, providing a benchmark for relative valuation. Vicarious Surgical Inc Corp (RBOT) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Vicarious Surgical Inc (RBOT) as of Jan 07 2026?
As of Jan 07 2026, Vicarious Surgical Inc (RBOT) has a P/B ratio of 1.07. This indicates that the market values RBOT at 1.07 times its book value.
What is the current FCF Yield for Vicarious Surgical Inc (RBOT) as of Jan 07 2026?
As of Jan 07 2026, Vicarious Surgical Inc (RBOT) has a FCF Yield of -280.03%. This means that for every dollar of Vicarious Surgical Inc’s market capitalization, the company generates -280.03 cents in free cash flow.
What is the current Forward P/E ratio for Vicarious Surgical Inc (RBOT) as of Jan 07 2026?
As of Jan 07 2026, Vicarious Surgical Inc (RBOT) has a Forward P/E ratio of -0.52. This means the market is willing to pay $-0.52 for every dollar of Vicarious Surgical Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Vicarious Surgical Inc (RBOT) as of Jan 07 2026?
As of Jan 07 2026, Vicarious Surgical Inc (RBOT) has a Forward P/S ratio of 0.00. This means the market is valuing RBOT at $0.00 for every dollar of expected revenue over the next 12 months.